SEARCH

SEARCH BY CITATION

References

  • Ades, L., Mary, J.Y., Robin, M., Ferry, C., Porcher, R., Esperou, H., Ribaud, P., Devergie, A., Traineau, R., Gluckman, E. & Socie, G. (2004) Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood, 103, 24902497.
  • Bacigalupo, A., Oneto, R., Bruno, B., Socie, G., Passweg, J., Locasciulli, A., Van Lint, M.T., Tichelli, A., McCann, S., Marsh, J., Ljungman, P., Hows, J., Marin, P. & Schrezenmeier, H. (2000) Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation. Acta Haematologica, 103, 1925.
  • Ballen, K.K., Spitzer, T.R., Yeap, B.Y., McAfee, S., Dey, B.R., Attar, E., Haspel, R., Kao, G., Liney, D., Alyea, E., Lee, S., Cutler, C., Ho, V., Soiffer, R. & Antin, J.H. (2007) Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biology of Blood and Marrow Transplantation, 13, 8289.
  • Bittencourt, H., Rocha, V., Chevret, S., Socie, G., Esperou, H., Devergie, A., Dal Cortivo, L., Marolleau, J.P., Garnier, F., Ribaud, P. & Gluckman, E. (2002) Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. Blood, 99, 27262733.
  • Brunstein, C.G., Barker, J.N., Weisdorf, D.J., DeFor, T.E., Miller, J.S., Blazar, B.R., McGlave, P.B. & Wagner, J.E. (2007) Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood, 110, 30643070.
  • Deeg, H.J., O’Donnell, M., Tolar, J., Agarwal, R., Harris, R.E., Feig, S.A., Territo, M.C., Collins, R.H., McSweeney, P.A., Copelan, E.A., Khan, S.P., Woolfrey, A. & Storer, B. (2006) Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood, 108, 14851491.
  • Fernandes, J., Rocha, V., Robin, M., De Latour, R.P., Traineau, R., Devergie, A., Ribaud, P., Rea, D., Larghero, J., Gluckman, E. & Socie, G. (2007) Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation. British Journal Haematology, 137, 248251.
  • Gluckman, E., Rocha, V., Ionescu, I., Biering, M., Arris, R.E., Wagner, J., Kurtzberg, J., Champagne, M.A., Bonfim, C., Bittencourt, M., Darbyshire, P., Fernandez, M., Locatelli, F. & Pasquini, R. (2007) Results of unrelated cord blood transplant in Fanconi anaemia patients: risk factor analysis for engraftment and survival. Biology of Blood and Marrow Transplantation, 13, 10731082.
  • Glucksberg, H., Storb, R., Fefer, A., Buckner, C.D., Neiman, P.E., Clift, R.A., Lerner, K.G. & Thomas, E.D. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation, 18, 295304.
  • Guardiola, P., Socie, G., Li, X., Ribaud, P., Devergie, A., Esperou, H., Richard, P., Traineau, R., Janin, A. & Gluckman, E. (2004) Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome. Blood, 103, 7377.
  • Locasciulli, A., Oneto, R., Bacigalupo, A., Socie, G., Korthof, E., Bekassy, A., Schrezenmeier, H., Passweg, J. & Fuhrer, M. (2007) Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica, 92, 1118.
  • Mao, P., Wang, S., Wang, S., Zhu, Z., Liv, Q., Xuv, Y., Mo, W. & Ying, Y. (2004) Umbilical cord blood transplant for adult patients with severe aplastic anemia using anti-lymphocyte globulin and cyclophosphamide as conditioning therapy. Bone Marrow Transplantation, 33, 3338.
  • Rocha, V. & Gluckman, E. (2006) Clinical use of umbilical cord blood hematopoietic stem cells. Biology of Blood and Marrow Transplantation, 12, 3441.
  • Rubinstein, P., Carrier, C., Scaradavou, A., Kurtzberg, J., Adamson, J., Migliaccio, A.R., Berkowitz, R.L., Cabbad, M., Dobrila, N.L., Taylor, P.E., Rosenfield, R.E. & Stevens, C.E. (1998) Outcomes among 562 recipients of placental-blood transplants from unrelated donors. New England Journal of Medicine, 339, 15651577.
  • Wagner, J.E., Barker, J.N., DeFor, T.E., Baker, K.S., Blazar, B.R., Eide, C., Goldman, A., Kersey, J., Krivit, W., MacMillan, M.L., Orchard, P.J., Peters, C., Weisdorf, D.J., Ramsay, N.K. & Davies, S.M. (2002) Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood, 100, 16111618.